| Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions RS McIntyre, DS Cha, JK Soczynska, HO Woldeyohannes, LA Gallaugher, ... Depression and anxiety 30 (6), 515-527, 2013 | 874 | 2013 |
| Inflamed moods: a review of the interactions between inflammation and mood disorders JD Rosenblat, DS Cha, RB Mansur, RS McIntyre Progress in Neuro-Psychopharmacology and Biological Psychiatry 53, 23-34, 2014 | 677 | 2014 |
| Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach RS McIntyre, MJ Filteau, L Martin, S Patry, A Carvalho, DS Cha, M Barakat, ... Journal of affective disorders 156, 1-7, 2014 | 487 | 2014 |
| The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project RS McIntyre, JZ Soczynska, HO Woldeyohannes, MT Alsuwaidan, ... Comprehensive Psychiatry 56, 279-282, 2015 | 184 | 2015 |
| The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder RS McIntyre, HX Xiao, K Syeda, M Vinberg, AF Carvalho, RB Mansur, ... CNS drugs 29, 577-589, 2015 | 159 | 2015 |
| Potential roles of zinc in the pathophysiology and treatment of major depressive disorder W Swardfager, N Herrmann, RS McIntyre, G Mazereeuw, K Goldberger, ... Neuroscience & biobehavioral reviews 37 (5), 911-929, 2013 | 148 | 2013 |
| Cannabidiol in medical marijuana: research vistas and potential opportunities C Rong, Y Lee, NE Carmona, DS Cha, RM Ragguett, JD Rosenblat, ... Pharmacological Research 121, 213-218, 2017 | 147 | 2017 |
| The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder RS McIntyre, MW Best, CR Bowie, NE Carmona, DS Cha, Y Lee, ... The Journal of clinical psychiatry 78 (7), 20938, 2017 | 135 | 2017 |
| Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry AMY Tai, A Albuquerque, NE Carmona, M Subramanieapillai, DS Cha, ... Artificial intelligence in medicine 99, 101704, 2019 | 131 | 2019 |
| Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study RB Mansur, J Ahmed, DS Cha, HO Woldeyohannes, M Subramaniapillai, ... Journal of affective disorders 207, 114-120, 2017 | 126 | 2017 |
| The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: results from the … RS McIntyre, JK Soczynska, DS Cha, HO Woldeyohannes, RS Dale, ... Journal of Affective Disorders 172, 259-264, 2015 | 123 | 2015 |
| Gut emotions-mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders A Slyepchenko, A F Carvalho, D S Cha, S Kasper, R S McIntyre CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 97 | 2014 |
| Predominant polarity as a course specifier for bipolar disorder: a systematic review AF Carvalho, RS McIntyre, D Dimelis, X Gonda, M Berk, PR Nunes-Neto, ... Journal of affective disorders 163, 56-64, 2014 | 96 | 2014 |
| Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder C Rong, C Park, JD Rosenblat, M Subramaniapillai, H Zuckerman, D Fus, ... International Journal of Environmental Research and Public Health 15 (4), 771, 2018 | 91 | 2018 |
| The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project RS McIntyre, JK Soczynska, SS Liauw, HO Woldeyohannes, E Brietzke, ... The International Journal of Psychiatry in Medicine 43 (2), 165-177, 2012 | 89 | 2012 |
| A new perspective on the anti-suicide effects with ketamine treatment: a procognitive effect Y Lee, K Syeda, NA Maruschak, DS Cha, RB Mansur, IK Wium-Andersen, ... Journal of clinical psychopharmacology 36 (1), 50-56, 2016 | 83 | 2016 |
| Treatment-emergent adverse events associated with atypical antipsychotics DS Cha, RS McIntyre Expert opinion on pharmacotherapy 13 (11), 1587-1598, 2012 | 82 | 2012 |
| Crosstalk between metabolic and neuropsychiatric disorders O Kaidanovich-Beilin, DS Cha, RS McIntyre F1000 biology reports 4, 2012 | 77 | 2012 |
| Advancing biomarker research: utilizing ‘Big Data’approaches for the characterization and prevention of bipolar disorder RS McIntyre, DS Cha, JM Jerrell, W Swardfager, RD Kim, LG Costa, ... Bipolar disorders 16 (5), 531-547, 2014 | 75 | 2014 |
| Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis. RB Mansur, Y Lee, AJ Zhou, NE Carmona, DS Cha, JD Rosenblat, ... Annals of clinical psychiatry: official journal of the American Academy of …, 2018 | 72 | 2018 |
